Cargando…

Utility values for age-related macular degeneration patients in Korea

PURPOSE: Age-related macular degeneration (AMD) is one of the most important causes of blindness globally and may lead to decreased quality of life. Utility values for AMD patients according to sociodemographic and clinical characteristics have been little-studied, particularly among Asian populatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Seulggie, Park, Sang Min, Jee, Donghyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067739/ https://www.ncbi.nlm.nih.gov/pubmed/30063734 http://dx.doi.org/10.1371/journal.pone.0201399

Ejemplares similares

Correction: Utility values for age-related macular degeneration patients in Korea
por: Choi, Seulggie, et al.
Publicado: (2018)

Utility values for glaucoma patients in Korea
por: Choi, Seulggie, et al.
Publicado: (2018)

The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ho, Ra, et al.
Publicado: (2018)

Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ra, Ho, et al.
Publicado: (2018)

Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ra, Ho, et al.
Publicado: (2018)

Association between Blood Lead Levels and Age-Related Macular Degeneration
por: Hwang, Ho Sik, et al.
Publicado: (2015)

Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
por: Choi, Seulggie, et al.
Publicado: (2018)

Age- and sex-based evaluation of the association between refractive error and age-related macular degeneration in the Korean population
por: Lee, Kook, et al.
Publicado: (2020)

The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
por: Choi, Jin A., et al.
Publicado: (2019)

Resource Utilization and Costs of Age-Related Macular Degeneration
por: Halpern, Michael T., et al.
Publicado: (2006)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Angiogenin in age-related macular degeneration
por: Skeie, Jessica M., et al.
Publicado: (2011)

Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration
por: van de Graaf, Elizabeth S., et al.
Publicado: (2016)

Healthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Kim, Ashley, et al.
Publicado: (2021)

Medication Trends for Age-Related Macular Degeneration
por: Cho, Yeon-Kyoung, et al.
Publicado: (2021)

Glycolysis in Patients with Age-Related Macular Degeneration
por: Yokosako, Kanako, et al.
Publicado: (2014)

Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration
por: Ma, Yingyan, et al.
Publicado: (2016)

Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
por: Poku, Edith, et al.
Publicado: (2013)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Age-Related Macular Degeneration and the Aging Brain
por: Whitson, Heather, et al.
Publicado: (2021)

Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration
por: Ozawa, Yoko, et al.
Publicado: (2017)

Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration
por: Kaiser, Peter K.
Publicado: (2007)

Fear of falling in age-related macular degeneration
por: van Landingham, Suzanne W, et al.
Publicado: (2014)

Screening for biomarkers in age-related macular degeneration
por: Han, Daoxin, et al.
Publicado: (2023)

Multiplexed plasma protein classifiers for the diagnosis of age‐related macular degeneration
por: Ahn, Hee‐Sung, et al.
Publicado: (2023)

Human pharyngeal microbiota in age-related macular degeneration
por: Ho, Eliza Xin Pei, et al.
Publicado: (2018)

Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration
por: Kim, Jaeryung, et al.
Publicado: (2019)

Dietary Patterns and Age-Related Macular Degeneration in Korea: The Korea National Health and Nutrition Examination Survey 2010–2011
por: Kang, Kyung Tae, et al.
Publicado: (2019)

LAMELLAR MACULAR HOLES IN THE PRESENCE OF AGE-RELATED MACULAR DEGENERATION
por: Francone, Anibal, et al.
Publicado: (2020)

Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients
por: Rosen, Richard, et al.
Publicado: (2009)

Gait Characteristics of Age-Related Macular Degeneration Patients
por: Varadaraj, Varshini, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ml79vvfj8s41pq3fchefvus1a7